These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34000641)

  • 1. Microbiota as a potentially-modifiable factor influencing COVID-19.
    Ngo VL; Gewirtz AT
    Curr Opin Virol; 2021 Aug; 49():21-26. PubMed ID: 34000641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Status in COVID-19: An Unrecognized Player?
    Donati Zeppa S; Agostini D; Piccoli G; Stocchi V; Sestili P
    Front Cell Infect Microbiol; 2020; 10():576551. PubMed ID: 33324572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiota-mediated dietary and nutritional interventions for COVID-19.
    Gasmi A; Tippairote T; Mujawdiya PK; Peana M; Menzel A; Dadar M; Benahmed AG; Bjørklund G
    Clin Immunol; 2021 May; 226():108725. PubMed ID: 33845194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.
    Heidari Z; Tajbakhsh A; Gheibihayat SM; Moattari A; Razban V; Berenjian A; Savardashtaki A; Negahdaripour M
    Recent Pat Biotechnol; 2021 Oct; 15(2):112-136. PubMed ID: 33874878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic.
    Lee E; Hong SJ
    Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):245-251. PubMed ID: 33769313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the intestinal microbiota in host defense against respiratory viral infections.
    Boncheva I; Poudrier J; Falcone EL
    Curr Opin Virol; 2024 Jun; 66():101410. PubMed ID: 38718575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
    Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
    Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome and anti-viral immunity in COVID-19.
    Rossini V; Tolosa-Enguis V; Frances-Cuesta C; Sanz Y
    Crit Rev Food Sci Nutr; 2024; 64(14):4587-4602. PubMed ID: 36382631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.
    Sulaiman I; Chung M; Angel L; Tsay JJ; Wu BG; Yeung ST; Krolikowski K; Li Y; Duerr R; Schluger R; Thannickal SA; Koide A; Rafeq S; Barnett C; Postelnicu R; Wang C; Banakis S; Pérez-Pérez L; Shen G; Jour G; Meyn P; Carpenito J; Liu X; Ji K; Collazo D; Labarbiera A; Amoroso N; Brosnahan S; Mukherjee V; Kaufman D; Bakker J; Lubinsky A; Pradhan D; Sterman DH; Weiden M; Heguy A; Evans L; Uyeki TM; Clemente JC; de Wit E; Schmidt AM; Shopsin B; Desvignes L; Wang C; Li H; Zhang B; Forst CV; Koide S; Stapleford KA; Khanna KM; Ghedin E; Segal LN
    Nat Microbiol; 2021 Oct; 6(10):1245-1258. PubMed ID: 34465900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
    Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
    Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Infections, the Microbiome, and Probiotics.
    Harper A; Vijayakumar V; Ouwehand AC; Ter Haar J; Obis D; Espadaler J; Binda S; Desiraju S; Day R
    Front Cell Infect Microbiol; 2020; 10():596166. PubMed ID: 33643929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
    Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
    Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
    Front Immunol; 2020; 11():607734. PubMed ID: 33569053
    [No Abstract]   [Full Text] [Related]  

  • 20. Host-microbiome interactions in acute and chronic respiratory infections.
    Taylor SL; Wesselingh S; Rogers GB
    Cell Microbiol; 2016 May; 18(5):652-62. PubMed ID: 26972325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.